by chuck_ltd | 29 Apr, 2016 | Biosimilars, CHCUK News & Articles, News
Biosimilars, otherwise known as subsequent entry biologics or “SEBs” in Canada, are a rapidly emerging trend in healthcare. There is a common misconception that biosimilars are “generic” biologic medications. In reality, biosimilars and traditional generic...
by chuck_ltd | 23 Dec, 2015 | CHCUK News & Articles, GCP, GCP Inspections
Clinical trials in Canada for human drugs must meet high safety standards. Canada inspects clinical trials to reduce the risks to people participating in the trials. To learn more about the clinical trial inspections we conduct, you can visit about clinical trial...
